Net Medical Xpress Solutions, Inc. (NMXS)
USD 0.01
(16.28%)
USD 0.01
(16.28%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.85 Million USD | -309.83% |
| 2022 | 885 Thousand USD | 8750.0% |
| 2021 | 10 Thousand USD | 102.0% |
| 2020 | -499 Thousand USD | -88.3% |
| 2019 | -265 Thousand USD | -2309.09% |
| 2018 | -11 Thousand USD | -111.58% |
| 2017 | 95 Thousand USD | 127.62% |
| 2016 | -344 Thousand USD | -327.81% |
| 2015 | 151 Thousand USD | 131.33% |
| 2014 | -482 Thousand USD | -1706.67% |
| 2013 | 30 Thousand USD | 500.0% |
| 2012 | 5000.00 USD | 102.23% |
| 2011 | -224 Thousand USD | 30.86% |
| 2010 | -324 Thousand USD | -113.16% |
| 2009 | -152 Thousand USD | 68.66% |
| 2008 | -485 Thousand USD | 34.37% |
| 2007 | -739 Thousand USD | 72.86% |
| 2006 | -2.72 Million USD | -159.83% |
| 2005 | -1.04 Million USD | -49.08% |
| 2004 | -703 Thousand USD | 20.48% |
| 2003 | -884 Thousand USD | -69.35% |
| 2002 | -522 Thousand USD | 76.7% |
| 2001 | -2.24 Million USD | 1.37% |
| 2000 | -2.27 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -202 Thousand USD | 20.47% |
| 2023 Q2 | -776 Thousand USD | -132.34% |
| 2023 Q1 | -334 Thousand USD | 29.24% |
| 2023 FY | -1.85 Million USD | -309.83% |
| 2023 Q4 | -254 Thousand USD | 48.48% |
| 2023 Q3 | -493 Thousand USD | 36.47% |
| 2022 Q2 | 403 Thousand USD | -45.83% |
| 2022 FY | 885 Thousand USD | 8750.0% |
| 2022 Q3 | 211 Thousand USD | -47.64% |
| 2022 Q1 | 744 Thousand USD | 148.0% |
| 2022 Q4 | -472 Thousand USD | -323.7% |
| 2021 Q4 | 300 Thousand USD | 345.9% |
| 2021 Q1 | -29 Thousand USD | 0.0% |
| 2021 Q2 | -139 Thousand USD | -379.31% |
| 2021 FY | 10 Thousand USD | 102.0% |
| 2021 Q3 | -122 Thousand USD | 12.23% |
| 2020 FY | -499 Thousand USD | -88.3% |
| 2019 FY | -265 Thousand USD | -2309.09% |
| 2018 Q2 | 11 Thousand USD | 115.28% |
| 2018 FY | -11 Thousand USD | -111.58% |
| 2018 Q1 | -72 Thousand USD | 0.0% |
| 2017 Q3 | -55 Thousand USD | 16.67% |
| 2017 FY | 95 Thousand USD | 127.62% |
| 2017 Q2 | -66 Thousand USD | -60.98% |
| 2017 Q1 | -41 Thousand USD | 70.92% |
| 2016 Q3 | -126 Thousand USD | -29.9% |
| 2016 Q1 | 20 Thousand USD | 137.04% |
| 2016 Q4 | -141 Thousand USD | -11.9% |
| 2016 Q2 | -97 Thousand USD | -585.0% |
| 2016 FY | -344 Thousand USD | -327.81% |
| 2015 Q4 | -54 Thousand USD | -151.43% |
| 2015 Q3 | 105 Thousand USD | 262.07% |
| 2015 FY | 151 Thousand USD | 131.33% |
| 2015 Q2 | 29 Thousand USD | -59.15% |
| 2015 Q1 | 71 Thousand USD | 123.91% |
| 2014 FY | -482 Thousand USD | -1706.67% |
| 2014 Q2 | -67 Thousand USD | -644.44% |
| 2014 Q1 | -9000.00 USD | 75.0% |
| 2014 Q4 | -297 Thousand USD | -172.48% |
| 2014 Q3 | -109 Thousand USD | -62.69% |
| 2013 Q1 | 53 Thousand USD | -10.17% |
| 2013 Q2 | 1000.00 USD | -98.11% |
| 2013 FY | 30 Thousand USD | 500.0% |
| 2013 Q4 | -36 Thousand USD | -400.0% |
| 2013 Q3 | 12 Thousand USD | 1100.0% |
| 2012 Q2 | -12 Thousand USD | 47.83% |
| 2012 Q1 | -23 Thousand USD | 61.02% |
| 2012 FY | 5000.00 USD | 102.23% |
| 2012 Q4 | 59 Thousand USD | 410.53% |
| 2012 Q3 | -19 Thousand USD | -58.33% |
| 2011 Q3 | -71 Thousand USD | 31.73% |
| 2011 Q2 | -104 Thousand USD | -1140.0% |
| 2011 Q1 | 10 Thousand USD | 103.39% |
| 2011 FY | -224 Thousand USD | 30.86% |
| 2011 Q4 | -59 Thousand USD | 16.9% |
| 2010 Q2 | -40 Thousand USD | 0.0% |
| 2010 Q4 | -295 Thousand USD | -2781.82% |
| 2010 Q3 | 11 Thousand USD | 127.5% |
| 2010 Q1 | - USD | 100.0% |
| 2010 FY | -324 Thousand USD | -113.16% |
| 2009 Q3 | -64 Thousand USD | -1.59% |
| 2009 FY | -152 Thousand USD | 68.66% |
| 2009 Q2 | -63 Thousand USD | -425.0% |
| 2009 Q4 | -13 Thousand USD | 79.69% |
| 2009 Q1 | -12 Thousand USD | 93.81% |
| 2008 FY | -485 Thousand USD | 34.37% |
| 2008 Q3 | -46 Thousand USD | 73.26% |
| 2008 Q2 | -172 Thousand USD | -135.62% |
| 2008 Q1 | -73 Thousand USD | 76.97% |
| 2008 Q4 | -194 Thousand USD | -321.74% |
| 2007 FY | -739 Thousand USD | 72.86% |
| 2007 Q4 | -317 Thousand USD | -79.1% |
| 2007 Q3 | -177 Thousand USD | -129.87% |
| 2007 Q2 | -77 Thousand USD | 54.17% |
| 2007 Q1 | -168 Thousand USD | 87.31% |
| 2006 Q1 | -360 Thousand USD | 55.39% |
| 2006 FY | -2.72 Million USD | -159.83% |
| 2006 Q4 | -1.32 Million USD | -169.65% |
| 2006 Q3 | -491 Thousand USD | 10.56% |
| 2006 Q2 | -549 Thousand USD | -52.5% |
| 2005 Q3 | 49 Thousand USD | 116.17% |
| 2005 Q4 | -807 Thousand USD | -1746.94% |
| 2005 Q2 | -303 Thousand USD | -2430.77% |
| 2005 Q1 | 13 Thousand USD | 102.29% |
| 2005 FY | -1.04 Million USD | -49.08% |
| 2004 FY | -703 Thousand USD | 20.48% |
| 2004 Q2 | 76 Thousand USD | 300.0% |
| 2004 Q3 | -232 Thousand USD | -405.26% |
| 2004 Q4 | -567 Thousand USD | -144.4% |
| 2004 Q1 | 19 Thousand USD | 105.99% |
| 2003 Q2 | -697 Thousand USD | -3004.17% |
| 2003 Q1 | 24 Thousand USD | 108.73% |
| 2003 Q3 | 106 Thousand USD | 115.21% |
| 2003 FY | -884 Thousand USD | -69.35% |
| 2003 Q4 | -317 Thousand USD | -399.06% |
| 2002 Q3 | -294 Thousand USD | -345.0% |
| 2002 Q1 | -74 Thousand USD | 79.33% |
| 2002 FY | -522 Thousand USD | 76.7% |
| 2002 Q4 | -275 Thousand USD | 6.46% |
| 2002 Q2 | 120 Thousand USD | 262.16% |
| 2001 Q3 | -485 Thousand USD | 47.62% |
| 2001 Q4 | -358 Thousand USD | 26.19% |
| 2001 FY | -2.24 Million USD | 1.37% |
| 2001 Q1 | -471 Thousand USD | 0.0% |
| 2001 Q2 | -926 Thousand USD | -96.6% |
| 2000 FY | -2.27 Million USD | 0.0% |
| 2000 Q1 | -594 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Achiko AG | -9.32 Million USD | 80.079% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | -5.18 Million USD | 64.219% |
| Cannabis Sativa, Inc. | -1.39 Million USD | -33.384% |
| CompuMed, Inc. | -32.6 Thousand USD | -5595.62% |
| CompuGroup Medical SE & Co. KGaA | 45.91 Million USD | 104.044% |
| Cogstate Limited | 5.44 Million USD | 134.074% |
| CareView Communications, Inc. | -3.95 Million USD | 53.015% |
| Craneware plc | 11.7 Million USD | 115.868% |
| Caduceus Software Systems Corp. | -13.96 Million USD | 86.699% |
| Certive Solutions Inc. | -1.67 Million USD | -11.189% |
| Drug Free Solution, Inc. | -1.4 Million USD | -31.957% |
| DATATRAK International, Inc. | 2.65 Million USD | 169.88% |
| Strainsforpains, Inc. | -182.18 Thousand USD | -919.282% |
| Healixa Inc. | -6.73 Million USD | 72.408% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 7.1 Million USD | 126.143% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -702.48 Thousand USD | -164.347% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | -789.33 USD | -235162.818% |
| IQ-AI Limited | -623.81 Thousand USD | -197.684% |
| Cannabiz Mobile, Inc. | -750.00 USD | -247500.0% |
| Mednow Inc. | -29.48 Million USD | 93.701% |
| Galileo Life Sciences, Inc. | -248.24 Thousand USD | -648.057% |
| MediXall Group, Inc. | -6.83 Million USD | 72.813% |
| Mitesco, Inc. | -13.33 Million USD | 86.071% |
| MobileSmith, Inc. | -14.12 Million USD | 86.856% |
| NantHealth, Inc. | -67.77 Million USD | 97.26% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -13.38 Million USD | 86.127% |
| Patient Access Solutions, Inc. | -10.59 Million USD | 82.471% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 241.736% |
| PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | 2585.012% |
| Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | -5345.588% |
| Renalytix Plc | -33.45 Million USD | 94.449% |
| Revium Recovery Inc. | -683 Thousand USD | -171.889% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | 313.06 Thousand USD | 693.173% |
| Vaso Corporation | 4.8 Million USD | 138.647% |
| Vynleads, Inc. | -263.43 Thousand USD | -604.912% |